Alphatec EPS ATEC
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$0.71
- Latest quarter, Q2 FY26
- −$0.16
- Fiscal year 2025
- −$0.95
Alphatec's earnings per share was −$0.71 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.16.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.95 | n/a |
| FY2024 | −$1.14 | n/a |
| FY2023 | −$1.55 | n/a |
| FY2022 | −$1.47 | n/a |
| FY2021 | −$1.49 | n/a |
| FY2020 | −$1.17 | n/a |
| FY2019 | −$1.10 | n/a |
| FY2018 | −$1.08 | n/a |
| FY2017 | −$0.56 | n/a |
| FY2016 | −$3.49 | n/a |
| FY2015 | −$19.54 | n/a |
| FY2014 | −$0.17 | n/a |
| FY2013 | −$0.85 | n/a |
| FY2012 | −$0.17 | n/a |
| FY2011 | −$0.24 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.16 | n/a | −$0.71 | |
| Q1 FY26 | −$0.22 | n/a | −$0.82 | |
| Q4 FY25 | −$0.14 | n/a | −$0.95 | |
| Q3 FY25 | −$0.19 | n/a | −$1.04 | |
| Q2 FY25 | −$0.27 | n/a | −$1.13 | |
| Q1 FY25 | −$0.35 | n/a | −$1.15 | |
| Q4 FY24 | −$0.23 | n/a | −$1.14 | |
| Q3 FY24 | −$0.28 | n/a | −$1.28 | |
| Q2 FY24 | −$0.29 | n/a | −$1.35 | |
| Q1 FY24 | −$0.34 | n/a | −$1.49 | |
| Q4 FY23 | −$0.37 | n/a | −$1.55 | |
| Q3 FY23 | −$0.35 | n/a | −$1.51 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Alphatec's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ATECAlphatec | −$0.71 | |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| EYENational Vision | $0.61 | |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| CDRECadre | $0.81 | −14% a year |
| BVSBioventus | $0.77 | |
| STAAStaar Surgical | $0.07 | |
| IRMDIradimed | $1.79 | +10% a year |
| ATRCAtriCure | $0.21 | |
| WRBYWarby Parker | $0.07 | |
| Peer median | $0.79 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Alphatec
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.